Skip to main content
. 2021 Jun 4;36:100931. doi: 10.1016/j.eclinm.2021.100931

Table 2.

Characteristics of convalescent plasma donors.

No Donor ID Age (years) Sex Time from onset of symptom to donation (days) Time from resolution of symptom to donation (days) Clinical stage during illness % Inhibition of CP unit to SARS-CoV-2§
1 TPT-D1011 56 M 28 14 Moderate −5.77
2 TPT-D1013 33 M 23 14 Moderate −9.29
3 TPT-D1018 23 F 21 14 Mild 63.41
4 TPT-D1019 51 F 21 15 Mild 82.97
5 TPT-D1020 35 M 20 14 Mild 78.08
6 TPT-D1022 33 M 23 14 Moderate 90.76
7 TPT-D1025 33 F 22 16 Mild 80.71
8 TPT-D1026 47 M 22 14 Moderate 89.65
9 TPT-D1029 42 M 41 20 Severe 91.40
10 TPT-D1030 49 M 29 14 Moderate 94.53
11 TPT-D2031 23 F 21 14 Mild 0.79

CP, convalescent plasma; According to Siddiqi & Mehra24

§Cut-off ≥20%.28.